Environment Protection Authority v Virotec International Limited

Environment Protection Authority v Virotec International Limited was a case before the Supreme Court of Victoria where the Environment Protection Authority (EPA) sought judicial review of a decision by Virotec International Limited, a company that manufactures and distributes industrial chemicals, to release a product containing diethylene glycol, a chemical deemed hazardous by the EPA. The EPA argued that the release of this product was in breach of its permit conditions and posed a risk to the environment and human health.

The central legal issues before the court were whether Virotec had complied with the conditions of its permit and whether the EPA had acted within its statutory powers when it issued a notice requiring Virotec to cease the release of the product. The court was required to examine the terms of the permit, the evidence regarding the risks posed by diethylene glycol, and the EPA's statutory authority in issuing the notice.

In its decision, the court found that Virotec had indeed breached the conditions of its permit by releasing a product that contained a hazardous substance without adequate risk assessment or management. The court held that the EPA's decision to issue a notice requiring Virotec to cease the release was within its statutory powers, and that the EPA had provided sufficient evidence to support its assessment of the risks associated with the product. The court further determined that the EPA's actions were reasonable and lawful, and that the permit conditions were clear and enforceable. Consequently, the court upheld the EPA's decision and dismissed Virotec's challenge to the EPA's actions.

The formal orders of the court were that Virotec International Limited be required to cease the release of the product in question and take appropriate steps to mitigate any environmental harm caused by the release. Additionally, the court ordered Virotec to comply with all permit conditions in the future and to undertake a comprehensive risk assessment for any new products before release.